1988
DOI: 10.1111/j.1600-0536.1988.tb02754.x
|View full text |Cite
|
Sign up to set email alerts
|

Contact allergy to metlpranolol

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
10
0

Year Published

1989
1989
2016
2016

Publication Types

Select...
7
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 23 publications
(10 citation statements)
references
References 8 publications
0
10
0
Order By: Relevance
“…Moreover, allergic reactions to ophthalmic drugs are probably more frequent than described in the literature so far. Diagnostic efforts to identify an alternative agent tolerated by the patient allergic to one P-blocker, led to the observation of delayed-type cross-reactivity between levobunol and carteolol, levobunol and timolol, levobunol and befunolol, befunolol and metipranolol, metipranolol and 1-penbutolol, and befunolol and carteolol in several cases, the development of cross-reactions so far not being predictable (11)(12)(13)(14)(15)(16)(17)(18)(19). Furthermore, it is a question if previous exposure to the "cross-reacting" compound (and concomitant sensitization) was excluded in every case of assumed cross-reaction.…”
mentioning
confidence: 99%
“…Moreover, allergic reactions to ophthalmic drugs are probably more frequent than described in the literature so far. Diagnostic efforts to identify an alternative agent tolerated by the patient allergic to one P-blocker, led to the observation of delayed-type cross-reactivity between levobunol and carteolol, levobunol and timolol, levobunol and befunolol, befunolol and metipranolol, metipranolol and 1-penbutolol, and befunolol and carteolol in several cases, the development of cross-reactions so far not being predictable (11)(12)(13)(14)(15)(16)(17)(18)(19). Furthermore, it is a question if previous exposure to the "cross-reacting" compound (and concomitant sensitization) was excluded in every case of assumed cross-reaction.…”
mentioning
confidence: 99%
“…Contact allergy to topically applied beta-adenergic receptor blocking agents is a recognized but infrequently reported side-effect of glaucoma treatment. Sensitization may involve a single agent, e.g., timolol (4-6), befunolol (7,8), metipranolol (8), and levobunolol (9), or to > 1 beta blocker in a single patient (10,11). The 3 patients of Van Joost et al (10), allergic to metoprolol, each reacted to 1 other beta-blocker (propranolol, practolol, timolol).…”
Section: Discussionmentioning
confidence: 99%
“…11,28,29 Using a standard series of test solutions, Lernia et al 23 showed positive patch test reactions to levobunolol in 1 patient that had negative reactions in 5 test subjects. This was similarly observed by Sanchez-Perez et al, 27 with 1 patient with a positive patch test reaction to carteolol, of which the test solutions were negative in 23 control patients.…”
Section: Beta-blockersmentioning
confidence: 98%